S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
OTCMKTS:DDXS

Diadexus Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
30 shs
Average Volume
15,481 shs
Market Capitalization
$53 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive DDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for Diadexus and its competitors with MarketBeat's FREE daily newsletter.


Diadexus logo

About Diadexus

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:DDXS
CUSIP
25245P106
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$53 thousand
Optionable
Not Optionable

Company Calendar

Last Earnings
10/26/2015
Today
12/09/2021

MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Diadexus (OTCMKTS:DDXS) Frequently Asked Questions

How were Diadexus' earnings last quarter?

Diadexus, Inc. (OTCMKTS:DDXS) released its earnings results on Monday, October, 26th. The company reported ($0.34) EPS for the quarter, beating the Zacks' consensus estimate of ($0.69) by $0.35.
View Diadexus' earnings history
.

Who are Diadexus' key executives?

Diadexus' management team includes the following people:
  • Kenneth Charles Fang, Chief Medical Officer
  • Amy Figueroa, Head-Investor Relations

What other stocks do shareholders of Diadexus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Diadexus investors own include GoPro (GPRO), General Electric (GE), Ambarella (AMBA) and Alliqua Biomedical (ALQA).

What is Diadexus' stock symbol?

Diadexus trades on the OTCMKTS under the ticker symbol "DDXS."

How do I buy shares of Diadexus?

Shares of DDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Diadexus make?

Diadexus has a market capitalization of $0.00.

What is Diadexus' official website?

The official website for Diadexus is www.diadexus.com.

Where are Diadexus' headquarters?

How can I contact Diadexus?

Diadexus' mailing address is 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States. The company can be reached via phone at (650) 246-6400.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.